Cytosorbents (CTSO) Revenue Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) Revenue Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 0.73% |
| 10 | Cytosorbents | 22.59 Mn | 17.79 Mn | 6.13 Mn | -2.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11% |
| Dec 31, 2025 | -0.56% |
| Sep 30, 2025 | 5.35% |
| Jun 30, 2025 | 4.22% |
| Mar 31, 2025 | 0.14% |
| Dec 31, 2024 | -5.32% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -9.74% |
| Mar 31, 2024 | -5.34% |
| Dec 31, 2023 | -10.16% |
| Sep 30, 2023 | -5.82% |
| Jun 30, 2023 | -1.29% |
| Mar 31, 2023 | 2.76% |
| Dec 31, 2022 | 8.12% |
| Sep 30, 2022 | 10.00% |
| Jun 30, 2022 | 10.88% |
| Mar 31, 2022 | 18.74% |
| Dec 31, 2021 | 21.04% |
| Sep 30, 2021 | 19.34% |
| Jun 30, 2021 | 27.84% |